Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Nasdaq Dips 3% As Nvidia, Other Chip Stocks Tumble: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
03:15am, Tuesday, 28'th Jan 2025
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the “Fear” zone on Monday.
Euronext to acquire Nasdaq's Nordic power futures business
02:00am, Tuesday, 28'th Jan 2025
Euronext to acquire Nasdaq's Nordic power futures business Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris / New York – 28 January 2025 – Euronext (Euronext: ENX), the leading European
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
08:30pm, Monday, 27'th Jan 2025
HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
BriaCell Announces Completion of 15:1 Share Consolidation
06:42pm, Monday, 27'th Jan 2025
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bio
Intelligent Living Application Group Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:30pm, Monday, 27'th Jan 2025
HONG KONG , Jan. 27, 2025 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer in Hong Kong, announced toda
Nasdaq Tumbles: NVIDIA, Broadcom and Microsoft Pull the Market Down
04:22pm, Monday, 27'th Jan 2025
The Nasdaq is currently experiencing a significant pullback.
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 15, 2025
04:05pm, Monday, 27'th Jan 2025
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 15, 2025, short interest in 3,099 Nasdaq Global MarketSM securities totaled 12,402,417,655 shares compared with
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards
04:05pm, Monday, 27'th Jan 2025
MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ch
Nasdaq clobbered, S&P 500 tumbles as AI fears rock Nvidia, tech stocks
01:49pm, Monday, 27'th Jan 2025
To get the latest market news check out finance.yahoo.com The Nasdaq sank on Monday to lead a stock sell-off on Wall Street as a Chinese startup rattled faith in US leadership and profitability in AI,
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
08:01am, Monday, 27'th Jan 2025
BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in
Lichen China Limited Announces Receipt of Notification from Nasdaq
08:00am, Monday, 27'th Jan 2025
XIAMEN, China , Jan. 27, 2025 /PRNewswire/ --Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced t
Nasdaq to slump as Nvidia leads Wall Street pummeling on global tech sell-off
06:42am, Monday, 27'th Jan 2025
Wall Street looked set to take a beating ahead of Monday's trading as a global technology sector sell-off sparked by China's DeepSeek threatened to weigh. Futures had the Nasdaq off 4.2% ahead of the
Is a Beat in the Cards for Nasdaq This Earnings Season?
10:01am, Friday, 24'th Jan 2025
NDAQ's Q4 performance is likely to have been driven by price increases, new sales, higher subscription revenues as well as growth in trading volume.
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
08:29am, Friday, 24'th Jan 2025
NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth Therapeutics"), a biopharmaceutical company, today announced that it has received notification f
Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
04:15pm, Thursday, 23'rd Jan 2025
SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment o
